adenylate cyclase activating polypeptide 1 ; Homo sapiens






359 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1315448 Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates cyclic AMP formation as well as peptide output of cultured pituitary melanotrophs and AtT-20 corticotrophs. Regul Pept 1992 Mar 5 14
2 1321043 Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. Eur J Biochem 1992 Jul 1 1
3 1321772 Pituitary adenylate cyclase-activating polypeptide stimulates secretion in T84 cells. Gastroenterology 1992 Aug 6
4 1335766 A novel hypothalamic peptide, pituitary adenylate cyclase activating peptide, modulates Sertoli cell function in vitro. Biol Reprod 1992 Nov 1
5 1383635 Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans. J Cardiovasc Pharmacol 1992 Jul 1
6 1481892 Analysis of systemic and pulmonary vascular responses to PACAP and VIP: role of adrenal catecholamines. Am J Physiol 1992 Dec 3
7 1483839 Pituitary adenylate cyclase activating polypeptide (PACAP) with 27 residues. Conformation determined by 1H NMR and CD spectroscopies and distance geometry in 25% methanol solution. Int J Pept Protein Res 1992 Nov 1
8 1649637 The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes. Biochim Biophys Acta 1991 Jul 22 6
9 1739432 Primary structure and characterization of the precursor to human pituitary adenylate cyclase activating polypeptide. DNA Cell Biol 1992 Jan-Feb 2
10 1847591 Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Am J Physiol 1991 Feb 4
11 7514549 PACAP-38 positively regulates glycoprotein hormone alpha-gene expression in placental cells. Mol Cell Endocrinol 1994 Feb 1
12 7515875 Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide-dependent activation of membrane-bound NO synthase in smooth muscle mediated by pertussis toxin-sensitive Gi1-2. J Biol Chem 1994 Jun 10 3
13 7585525 Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells. Cancer Res 1995 Nov 1 6
14 7623776 Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity. Mol Pharmacol 1995 Jul 8
15 7643128 Pituitary adenylate cyclase-activating polypeptide (PACAP) regulation of sympathetic neuron neuropeptide Y and catecholamine expression. J Neurochem 1995 Sep 7
16 7761627 Helospectin and pituitary adenylate cyclase activating polypeptide in the human vagina. Regul Pept 1995 Feb 14 2
17 7768322 Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol 1995 Jan 4
18 7862259 Pertussis toxin pretreatment enhances catecholamine secretion induced by pituitary adenylate cyclase-activating polypeptide in cultured porcine adrenal medullary chromaffin cells: a possible role of the inositol lipid cascade. Neuropeptides 1994 Nov 11
19 7884155 Regulation of the descending relaxation phase of intestinal peristalsis by PACAP. J Auton Nerv Syst 1994 Dec 15 3
20 7903438 Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells. Neurosci Lett 1993 Sep 3 2
21 7913440 Enhanced production of pituitary adenylate-cyclase-activating polypeptide by 1, N6-dibutyryladenosine 3',5'-monophosphate, phorbol 12-myristate 13-acetate and by the polypeptide itself in human neuroblastoma cells, IMR-32. Eur J Biochem 1994 Jul 1 6
22 7937342 Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors. Peptides 1994 1
23 7946970 Inhibition of protein phosphatases by okadaic acid and calyculin-A differentially modulates hormonal- and forskolin-stimulated formation of cyclic AMP in AtT-20 corticotrophs: effect of pituitary adenylate activating polypeptide and corticotropin-releasing factor. Cell Signal 1994 May 6
24 7988467 Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland. Endocrinology 1994 Dec 2
25 8019839 PACAP is a potent and highly effective stimulator of adenylyl cyclase activity in the retinas of different mammalian species. Brain Res 1994 Mar 28 2
26 8071835 Inhibitory transmission in tenia coli mediated by distinct vasoactive intestinal peptide and apamin-sensitive pituitary adenylate cyclase activating peptide receptors. J Pharmacol Exp Ther 1994 Aug 2
27 8134291 Contrasting effects of PACAP and carbachol on [Ca2+]i and inositol phosphates in human neuroblastoma NB-OK-1 cells. Peptides 1993 Nov-Dec 3
28 8218337 Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim Biophys Acta 1993 Oct 29 1
29 8308455 Localization, characterization and activity of pituitary adenylate cyclase-activating polypeptide in the frog adrenal gland. J Endocrinol 1993 Nov 2
30 8344311 Two salmon neuropeptides encoded by one brain cDNA are structurally related to members of the glucagon superfamily. Eur J Biochem 1993 Jul 15 1
31 8353512 Dinucleotide repeat polymorphism at the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Hum Mol Genet 1993 Jun 2
32 8384124 Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages. FEBS Lett 1993 Mar 15 4
33 8384995 Ca(2+)-dependent stimulatory effect of pituitary adenylate cyclase-activating polypeptide on catecholamine secretion from cultured porcine adrenal medullary chromaffin cells. Endocrinology 1993 Apr 18
34 8387187 Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells. Peptides 1993 Mar-Apr 14
35 8547947 Mechanism of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in human nonfunctioning pituitary tumors. J Neuroendocrinol 1995 Sep 7
36 8550747 Pituitary adenylate-cyclase activating peptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines. J Clin Endocrinol Metab 1996 Jan 7
37 8564257 Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum. Br J Pharmacol 1995 Oct 2
38 8576167 A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide. J Biol Chem 1996 Jan 19 1
39 8663363 Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. J Biol Chem 1996 Jul 19 2
40 8680719 Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter. Br J Pharmacol 1995 Dec 1
41 8700120 Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol Pharmacol 1996 Jul 1
42 8728481 The effect of pituitary adenylate cyclase activating peptide (PACAP) on the nociceptive formalin test. Neurosci Lett 1996 Apr 5 4
43 8754770 Pituitary adenylate cyclase-activating polypeptide acts within the medial basal hypothalamus to inhibit prolactin and luteinizing hormone secretion. Endocrinology 1996 Aug 1
44 8758916 Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist. Cancer Res 1996 Aug 1 1
45 8771559 Pituitary adenylate cyclase-activating polypeptide induces gene expression of the catecholamine synthesizing enzymes, tyrosine hydroxylase and dopamine beta hydroxylase, through 3',5'-cyclic adenosine monophosphate- and protein kinase C-dependent mechanisms in cultured porcine adrenal medullary chromaffin cells. Neuropeptides 1996 Apr 15
46 8817243 Pituitary adenylate cyclase-activating polypeptide directly stimulates LH and FSH secretion by human pituitary gonadotrophinomas. Exp Clin Endocrinol Diabetes 1996 4
47 8857610 Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion. Neuroendocrinology 1996 Aug 6
48 8863853 Pituitary adenylate cyclase-activating peptide, carbachol, and glucose stimulate insulin release in the absence of an increase in intracellular Ca2+. Mol Pharmacol 1996 Oct 1
49 8914856 Switches in the expression and function of PACAP and VIP receptors during phenotypic interconversion in human neuroblastoma cells. Neuropeptides 1996 Aug 1
50 8923513 VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor. Neuropeptides 1996 Oct 4